
Early MASH risk stratification, drug choice, and aligned coverage could improve outcomes, explained Zobair Younossi, MD.
Supplements and Featured Publications
over 30 years ago
Introductionover 30 years ago
Epidemiology of Low Bone Mass and Fracturesover 30 years ago
Biochemical Markers in the Diagnosis and Treatment of Osteoporosisover 30 years ago
Treatment of Osteoporosisover 30 years ago
Review Article: Osteoporosis Revisitedover 30 years ago
CME Quiz





